Beijing Tiantan Biological Products Co., Ltd. Share Price
Equities
600161
CNE000000WF9
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.58 CNY | +1.60% |
|
+2.24% | -10.77% |
| 04-29 | Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-29 | Beijing Tiantan Biological Products Q1 net profit down 48.5% y/y | RE |
| Capitalization | 28.83B 4.24B 3.6B 3.3B 3.11B 5.8B 404B 5.85B 39.1B 15.26B 193B 15.92B 15.58B 666B | P/E ratio 2026 * |
33.6x | P/E ratio 2027 * | 20.8x |
|---|---|---|---|---|---|
| Enterprise value | 26.25B 3.86B 3.28B 3B 2.83B 5.28B 368B 5.32B 35.61B 13.9B 175B 14.5B 14.19B 607B | EV / Sales 2026 * |
4.53x | EV / Sales 2027 * | 3.4x |
| Free-Float |
46.44% | Yield 2026 * |
1.08% | Yield 2027 * | 1% |
| 1 day | +1.60% | ||
| 1 week | +2.24% | ||
| Current month | +2.24% | ||
| 1 month | -2.15% | ||
| 3 months | -11.64% | ||
| 6 months | -21.70% | ||
| Current year | -10.77% |
| 1 week | 14.04 |  | 14.63 |
| 1 month | 14.04 | | 15.67 |
| Current year | 14.04 | | 17.58 |
| 1 year | 14.04 | | 22.08 |
| 3 years | 14.04 | | 27.6 |
| 5 years | 12.44 | | 32.15 |
| 10 years | 7.56 | | 37.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hui Chuan Yang
CEO | Chief Executive Officer | 59 | 15/01/2026 |
Bo Tian
IRC | Investor Relations Contact | - | 28/02/2006 |
Xiang Ci
SEC | Corporate Secretary | 47 | 31/12/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Hui Chuan Yang
CHM | Chairman | 59 | 04/12/2022 |
Li Gang Hu
BRD | Director/Board Member | 52 | 24/05/2017 |
Jing Jin Zhu
CHM | Chairman | 64 | 31/10/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.37% | 0% | 37 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.60% | +2.24% | -23.58% | -33.83% | 4.17B | |
| -0.30% | +0.50% | +35.05% | -4.40% | 72.73B | |
| +0.73% | +3.19% | +52.77% | +178.59% | 52.45B | |
| -0.95% | +45.80% | +45.80% | +45.80% | 46.63B | |
| -4.24% | -22.20% | -58.84% | -68.41% | 42.13B | |
| +2.33% | +5.74% | +67.51% | -36.26% | 28.56B | |
| -2.70% | +11.80% | +118.06% | -58.82% | 21.57B | |
| -1.94% | -4.54% | +68.42% | +126.28% | 19.95B | |
| +1.79% | +3.27% | +70.09% | +56.33% | 19.69B | |
| +2.02% | +2.83% | +48.10% | +90.72% | 16.32B | |
| Average | -0.14% | +2.07% | +42.34% | +29.60% | 32.42B | |
| Weighted average by Cap. | -0.46% | +1.14% | +39.73% | +33.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.8B 854M 724M 663M 626M 1.17B 81.34B 1.18B 7.87B 3.07B 38.74B 3.2B 3.14B 134B | 7.11B 1.05B 888M 814M 767M 1.43B 99.75B 1.44B 9.65B 3.77B 47.51B 3.93B 3.85B 164B |
| Net income | 1.29B 190M 161M 148M 139M 260M 18.12B 262M 1.75B 684M 8.63B 714M 699M 29.87B | 1.52B 224M 190M 174M 164M 307M 21.38B 309M 2.07B 807M 10.18B 842M 824M 35.24B |
| Net Debt | -2.58B -379M -322M -295M -278M -518M -36.14B -523M -3.5B -1.36B -17.21B -1.42B -1.39B -59.56B | -4.63B -681M -578M -530M -499M -931M -64.91B -939M -6.28B -2.45B -30.92B -2.56B -2.5B -107B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/05/26 | 14.58 ¥ | +1.60% | 15,387,390 |
| 08/05/26 | 14.35 ¥ | +1.49% | 11,011,390 |
| 07/05/26 | 14.14 ¥ | -0.35% | 10,041,850 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600161 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition